上海生物制品研究所有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
69
NMPA:69
Drug Approvals
H1N1 Influenza A Vaccine(Split Virion),Inactivated
- Product Name
- 甲型H1N1流感病毒裂解疫苗
- Approval Number
- 国药准字S20090018
- Approval Date
- Aug 13, 2024
NMPA
H1N1 Influenza A Vaccine(Split Virion),Inactivated
- Product Name
- 甲型H1N1流感病毒裂解疫苗
- Approval Number
- 国药准字S20090017
- Approval Date
- Aug 13, 2024
NMPA
Influenza Vaccine (Split Virion), Inactivated，Quadrivalent
- Product Name
- 四价流感病毒裂解疫苗
- Approval Number
- 国药准字S20210007
- Approval Date
- Nov 22, 2022
NMPA
Measles, Mumps and Rubella Combined Vaccine,Live
- Product Name
- 麻腮风联合减毒活疫苗
- Approval Number
- 国药准字S20070026
- Approval Date
- Jun 27, 2022
NMPA
BCG Vaccine for Intradermal Injection
- Product Name
- 皮内注射用卡介苗
- Approval Number
- 国药准字S20013038
- Approval Date
- Apr 26, 2020
NMPA
Measles and Mumps Combined Vaccine,Live
- Product Name
- 麻疹腮腺炎联合减毒活疫苗
- Approval Number
- 国药准字S20000028
- Approval Date
- Apr 26, 2020
NMPA
BCG Vaccine for Intradermal Injection
- Product Name
- 皮内注射用卡介苗
- Approval Number
- 国药准字S20013039
- Approval Date
- Apr 26, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found